基本信息
views: 36
Career Trajectory
Bio
研究方向为肿瘤药理学,长期致力于肿瘤调控新机制和新靶点研究,并基于相应的分子靶点进行抗肿瘤新药研究。相关成果近五年于Blood、Nature Chemical Biology、Nature Communications、Oncogene、Cell Death and Differentiation等期刊发表SCI论文70余篇,3篇入选ESI高被引;先后主持国家自然科学基金面上项目、国家重大新药创制专项子课题等国家级项目7项;参编专著4本,获浙江省首届青年科技英才奖、中国药理学会施维雅青年药理学家奖,并获浙江省自然科学一等奖、教育部自然科学二等奖在内的科技奖励6次,授权发明专利11项,I类新药临床批件2项。入选教育部青年长江学者、科技部重点领域创新团队、浙江省万人计划青年拔尖人才、浙江省钱江人才计划、浙江省151人才工程培养对象二层次、浙江省医坛新秀等,兼任浙江省药理学会秘书长、浙江省药学会药理专委会副主委、中国抗癌协会抗癌药物专委会委员、中国药理学会教学专委会委员、中国药理学会生化与分子药理学专委会委员、中国抗癌协会小儿肿瘤专业委员会新技术开发专业组副组长等职,担任《药学学报》中英文刊、《Basic & Clinical Pharmacology & Toxicology》、《药学进展》、《中国现代应用药学》等期刊编委。
Research Interests
Papers共 121 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Acta Pharmacologica Sinicano. 2 (2024): 298-311
CANCER IMMUNOLOGY RESEARCHno. 2 (2024): 275-275
Mingfei Wu, Wei Wang, Xinfei Mao, Yiquan Wu, Yuyuan Jin, Tao Liu, Yan Lu, Haibin Dai, Shenxin Zeng, Wenhai Huang, Yuwei Wang,Xiaojun Yao,
European journal of medicinal chemistry (2024): 116539-116539
Mingfei Wu,Wei Wang, Xinfei Mao, Yiquan Wu,Yuyuan Jin,Tao Liu, Yan Lu,Haibin Dai,Shenxin Zeng,Wenhai Huang,Yuwei Wang,Xiaojun Yao,
European Journal of Medicinal Chemistry (2024)
Mingfei Wu,Wei Wang, Xinfei Mao, Yiquan Wu,Yuyuan Jin,Tao Liu,Yan Lu,Haibin Dai,Shenxin Zeng,Wenhai Huang,Yuwei Wang,Xiaojun Yao,
European Journal of Medicinal Chemistrypp.116539, (2024)
Cancer immunology researchno. 2 (2024): 275-275
Acta Pharmaceutica Sinica Bno. 4 (2023): 1522-1536
Bloodno. 4 (2023): 365-381
Qian Zhou, Miao Xian, Senfeng Xiang, Danyan Xiang, Xuejing Shao, Jincheng Wang, Ji Cao, Xiaochun Yang,Bo Yang,Meidan Ying, Qiaojun He
crossref(2023)
Biochemical pharmacology (2023): 115810-115810
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn